科学研究

学术报告

阿尔茨海默病早期诊断方法研究进展及临床应用

    |    分享:
2020-08-04

Seminar Type

Lecture Series on Neuropsychiatric Disorders


Preferred Location

Online Zoom Meeting Link:  https://zoom.com.cn/j/85328263314?pwd=MWhhb3BQM1QxY0wyK1pmY1ZlVlBaUT09

Meeting ID:  853 2826 3314

Password:  091314


Time

10:00-11:30, Friday, August 7th, 2020


Speaker

Huali Wang, MD, PhD

Professor of Geriatric Psychiatry

Chair, Clinical Research Division

Director, Dementia Care & Research Center

Associate Director, Beijing Dementia Key Lab

Peking University Institute of Mental Health

王华丽 博士

北京大学精神卫生研究所老年精神病学教授、临床研究部主任、老年痴呆护理研究中心主任、北京老年痴呆重点实验室副主任


Host

Dr. Dai Zhang


Topic

Early detection of Alzheimer's disease: research advance and translational implications

阿尔茨海默病早期诊断方法研究进展及临床应用


Abstract

Alzheimer's disease has emerged as a global public health concern. Among the seven themes of the WHO global action plan, early diagnosis and treatment is the key to secure the support for the persons with dementia. However, the etiology of Alzheimer's disease has not been fully elucidated. There are no specific ways of making an early diagnosis. The talk will review the current progress of establishing valid neuropsychological tests, discovering novel biomarkers, and developing optimal algorithms for the early detection of Alzheimer's disease. Besides, how the newly developed approaches might fit the clinical application will be discussed with case demonstration.


Speaker Biography

Dr. Wang obtained Bachelor of Medicine from Peking University (formerly, Beijing Medical University) in 1994, and MD/PhD from Peking University in 2001. She was trained on International Mental Health Research at Harvard Medical School, neuropsychology and neuroimaging of dementia at University of California, Irvine.

Dr. Wang is one of the national pioneers to manage memory clinic and build service capacity for dementia care. She set up the first dementia caregiver support group in China in 2000, developed and tested a community-based family caregiver support program in Beijing. Now she directs a training program for community doctors and service providers, and a train-the-trainer program for dementia caregivers support in China. The care model has been partly adopted by WHO West Pacific Regional Office to develop the toolkit for community-based dementia care in low- and middle-income countries.

Dr. Wang is leading the National Platform on Clinical Dataset and Biobank of Major Mental Disorders. Her research interest included: (1) exploring neuropsychological profiles, blood-based biomarkers and imaging features for early diagnosis of dementia; (2) developing culturally sensitive care for persons with dementia and their caregivers.

Besides, she has joined the panel  of the WHO priority setting exercise on dementia research, participated in the advisory board of WHO West Pacific Regional Office to develop the toolkit for community-based dementia care in low and middle-income countries, and has been designated by the National Health Commission as the WHO Global Dementia Observatory Focal Point for China. In addition, Prof. Wang is one of the technical advisers for dementia care and service in National Health Committee. She drafted the National Geriatric Mental Health Plan which was one the key elements of the 13th Five-Year Plan for Health Aging.